protein

Recombinant Human CD3 delta/CD3d Fc Chimera Protein, CF

10280-TC-050

50 ug

423 USD

10280-TC

10280-TC-050

Recombinant Human CD3 delta/CD3d Fc Chimera Protein, CF

The Recombinant Human CD3 delta/CD3d Fc Chimera Protein, CF from R&D Systems is derived from HEK293. The Recombinant Human CD3 delta/CD3d Fc Chimera Protein, CF has been validated for the following applications: Bioactivity.

CD3 delta/CD3d

Proteins and Enzymes

50 ug

Lyophilized from a 0.2 µm filtered solution in PBS.

Unconjugated

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Human

45-55 kDa, under reducing conditions

36 kDa

Measured by its binding ability in a functional ELISA. When Recombinant Human CD3 delta/CD3d Fc Chimera (Catalog # 10280-TC) is immobilized at 1.0 µg/mL, 100 µL/well, the concentration of Recombinant Human CD3E Fc Chimera Biotinylated Protein that produces 50% of the optimal binding response is approximately 1.0-6.0 µg/mL.

<0.10 EU per 1 µg of the protein by the LAL method.

P04234

Bioactivity

HEK293-derived Recombinant Human CD3 delta/CD3d Fc Chimera Protein

423 USD

CD3 antigen, delta subunit, CD3D, CD3d antigen, CD3d antigen, delta polypeptide (TiT3 complex), CD3d molecule, delta (CD3-TCR complex), CD3-DELTA, T3DOKT3, delta chain, T-cell receptor T3 delta chain, T-cell surface glycoprotein CD3 delta chain

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.